August 19, 2026
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: Back to District Court? PTAB Strategic Recalibration in Patent Litigation
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Biotechnology > Back to District Court? PTAB Strategic Recalibration in Patent Litigation
Biotechnology

Back to District Court? PTAB Strategic Recalibration in Patent Litigation

By Newsroom
Last updated: February 22, 2026
1 Min Read
Share


For years, parallel proceedings at the Patent Trial and Appeal Board (PTAB) were the near-automatic response of a defendant in district court patent litigation. Accused infringers routinely filed petitions—especially inter partes review (IPR) petitions—challenging validity of the asserted patents at the PTAB. Given the PTAB’s technical expertise, historically favorable invalidation rates, and lower standard of review on invalidity, this has been a favored approach among defendants.

Today, that reflexive approach warrants reconsideration. Recent developments at the PTAB have prompted both patent owners and accused infringers to reassess…



Source link

Share This Article
Facebook Email Copy Link Print

HOT NEWS

Nestlé sold treated water as ‘natural’ in alleged marketing fraud

Environmental Science
May 23, 2025

Exploring the Reventador Volcano: JETOUR G700 and Ed Stafford Redefine the Adventure Experience

Wuhu, Anhui, China — (ARAB NEWSWIRE) — Recently, the first episode of JETOUR’s Adventure of…

August 17, 2026

تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك

California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…

April 5, 2025

Arab Newswire Provides Press Release Distribution in Arabic

Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…

April 5, 2025

YOU MAY ALSO LIKE

Federal Circuit Reverses $4.7M Verdict in Labcorp v. QIAGEN: Claim Scope and Doctrine of Equivalents in the Crosshairs

The Federal Circuit recently reversed a $4.7M verdict in a patent lawsuit involving two patents concerning next-generation sequencing methods—U.S. Patent…

Biotechnology
December 21, 2025

Their Grip on s. 102 Inquiries |

So that I don’t have to explain the claims and the arguments presented by the parties, please read my posts…

Biotechnology
July 4, 2025

Obviousness-type double patenting in the Age of the Twenty-Year Term and Patent Term Adjustment |

Obviousness-type double patenting (ODP) attempts to prevent the term of a “reference patent” claiming an obvious variant of a parent…

Biotechnology
April 5, 2025

Updates on APEX-related Personal Jurisdiction Considerations Since SnapRays

Last year we discussed the implications of the Supreme Court’s choice not to review the Federal Circuit’s SnapRays decision for…

Biotechnology
February 8, 2026
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

Exploring the Reventador Volcano: JETOUR G700 and Ed Stafford Redefine the Adventure Experience
August 17, 2026
This week in Drug Discovery (10-14 August 2026) 
August 17, 2026
Submit ACS Spring 2027 Abstracts by September 28th
August 16, 2026
Pre-Surgical Complications (Part 5) – The Health Care Blog
August 16, 2026

Life Science Magazines

A New Blueprint: Innovations in DNA Synthesis
July 7, 2026
Inside HCP Decision-Making – The 2026 Access Landscape
July 6, 2026
Checklist for Submitting to an Institutional Review Board
July 2, 2026
Unlocking the Power of Primary Care in Cronic Disease Research
July 2, 2026

LS Newswire Service™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?